Wealth Outlook 2024 - Slow then grow

94 Wealth Outlook 2024 | Unstoppable trends For investors, healthcare innovation is on sale FIGURE 1 Share price returns for the pair of manufacturers responsible for the two leading GLP-1 weight loss drugs versus the rest of the developed market Healthcare sector Jan 2022 = 100 MSCI AC World Health Care Leading GLP-1 drugmakers 22O 180 140 100 60 JAN 22 JUL 22 JAN 23 JUL 23 Source: Bloomberg as of November 22, 2023. Indices are unmanaged. An investor cannot invest directly in an index. They are shown for illustrative purposes only and do not represent the performance of any specific investment. Index returns do not include any expenses, fees or sales charges, which would lower performance. Past performance is no guarantee of future results. Real results may vary.